We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Latex Agglutination Test Identifies Bacterial Groups

By LabMedica International staff writers
Posted on 06 Dec 2011
The latex agglutination kit offers a faster streptococci-grouping solution than traditional methods for all clinically significant groups. More...


The kit is designed to improve workflow efficiencies since the nitrous acid extraction instantaneously extracts the cell antigens and the test does not require rehydration or incubation.

Beta-hemolytic streptococci may be identified rapidly and accurately according to the presence of specific cell wall antigens in a process called Lancefield Grouping. This process is most conveniently carried out using latex agglutination. To prepare the antigens for a latex agglutination reaction, an enzyme-mediated or nitrous acid extraction method may be used. Commercially available nitrous acid extraction kits are not traditionally capable of detecting group D antigen.

The PathoDxtra Strep Grouping Kit a latex agglutination kit from Thermo Fisher Scientific (Basingstoke, UK), detects groups A, B, C, D, F, and G antigen using a nitrous acid extraction method. The company report that a test panel of 131 beta-hemolytic streptococci have been assayed, including: Lancefield 21 group A, 27 B, 20 C , 23 D, 20 F, and 20 G. Thirty non-Lancefield group isolates were also tested, including: Streptococcus pneumoniae, S. viridans, Staphylococcus aureus, and Listeria monocytogenes. The kit was compared with other commercial kits.

All kits showed 100% accuracy in identifying all Lancefield group A and group C isolates. For the remaining isolates, PathoDxtra Strep Grouping Kit performed better than or comparable to all other products examined. The overall performance of kits that included a group D latex showed that PathoDxtra Strep Grouping Kit correctly identified 150/161 (93.2%) of the isolates tested. PathoDxtra Strep Grouping Kit agglutination reactions were consistently strong and exhibited a fast agglutination reaction for all Lancefield groups, providing results within 20 seconds.

Julie Elston, global product manager, immunodiagnostics, at Thermo Fisher said, "Acid extraction kits offered speed but did not detect group D strep reliably, while enzyme kits detected all groups but required rehydration and incubation steps, adding significant time to testing procedures. With PathoDxtra there is no compromise, this kits gives instantaneous extraction and detects all clinically significant streps reliably, including group D. It really couldn’t be simpler.”

Related Links:
Thermo Fisher Scientific



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.